Standard Biotools Inc (LAB) stock news · rev $85.3M
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
This LAB news page leads with what Standard Biotools Inc filed — not a scraped headline mill.
No cached 8-K sentence for LAB yet. We will not pad this page with generic market recap.
Latest reported LAB revenue for 2025-12-31 was $85.3M. Net income was -$74.9M. Revenue was down 51.1% from 2024-12-31 to 2025-12-31. LAB currently screens at market cap $317.1M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the LAB stock page; for the tape open the quote page.
LAB stock news FAQ
What are LAB's latest revenue and net income?
Latest cached Standard Biotools Inc (LAB) revenue for Dec 31, 2025 was $85.3M. Net income was -$74.9M. Statements: https://lician.com/financials/lab
How did LAB revenue change from the prior cached period?
Cached Standard Biotools Inc (LAB) revenue was down 51.1% from $174.4M (Dec 31, 2024) to $85.3M (Dec 31, 2025). Statements: https://lician.com/financials/lab
What is LAB's market cap?
Standard Biotools Inc (LAB) market cap is $317.1M on the latest cached fundamentals snapshot.
What kind of company is LAB?
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Where is LAB stock news listed?
Cached stock news for Standard Biotools Inc (LAB) is listed at https://lician.com/news/lab. Filings: https://lician.com/sec/lab
Not investment advice.